Beijing, Beijing, China Youchoose Capital appeared to be the VC, which was created in 2014. The company was established in Asia in China. The leading representative office of defined VC is situated in the Beijing.
The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2017.
Among the most popular fund investment industries, there are Biotechnology, Genetics. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight HaploX Biotechnology.
The standard case for the fund is to invest in rounds with 2 partakers. Despite the Youchoose Capital, startups are often financed by SBCVC. The meaningful sponsors for the fund in investment in the same round are SBCVC, Kexin Capital. In the next rounds fund is usually obtained by Shenzhen Capital Group.
The fund was created by Hucheng Zhang.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Maxi Novel | $30M | 21 Jan 2021 | Beijing, Beijing, China | ||
Lynxi Technology | 01 Aug 2018 | Beijing, Beijing, China | |||
Atom Bioscience & Pharmaceutical | $3M | 21 Jun 2018 | Zhenjiang, Guangdong Province | ||
| $3M | 01 Feb 2018 | China, Zhangjiagang | |||
HaploX Biotechnology | $32M | 29 Dec 2017 | Futian District, Guangdong Province |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Maxi Novel | $30M | 21 Jan 2021 | Beijing, Beijing, China | ||
Lynxi Technology | 01 Aug 2018 | Beijing, Beijing, China | |||
Atom Bioscience & Pharmaceutical | $3M | 21 Jun 2018 | Zhenjiang, Guangdong Province | ||
| $3M | 01 Feb 2018 | China, Zhangjiagang | |||
HaploX Biotechnology | $32M | 29 Dec 2017 | Futian District, Guangdong Province |
